| Daniel Chung, MD | |
|
865 N Arizola Rd, Casa Grande, AZ 85122-6011 | |
| (520) 836-3446 | |
| (520) 836-8807 |
| Full Name | Daniel Chung |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 39 Years |
| Location | 865 N Arizola Rd, Casa Grande, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821091984 | NPI | - | NPPES |
| 031815 | Other | AZ | MEDICARE |
| 031813 | Other | AZ | MEDICARE |
| 031820 | Other | AZ | MEDICARE |
| 031814 | Other | AZ | MEDICARE |
| ZFQ31815 | Other | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 29727 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Casa Grande Medical Center | Casa grande, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sun Life Family Health Center Inc | 9335032275 | 47 |
News Archive
Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify which patients are more likely to survive by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation, according to researchers at NYU Langone Medical Center.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
ChemGenex Pharmaceuticals Limited and Hospira, Inc. announced today that they have entered into an exclusive agreement to license, develop and commercialize ChemGenex's product candidate omacetaxine mepesuccinate, a novel targeted cytotoxic pharmaceutical product, in Europe, the Middle East and parts of Africa (the Territory).
AG Mednet, the world's largest medical image collection and delivery service announced today that the steady state volume of images transferred by its managed service has surpassed the 2 million/month mark. The company achieved impressive growth in utilization in 2010.
An international research group led by the Centenary Institute has developed a world first genetic risk score (GRS) test able to identify patients at high-risk of developing alcohol-related cirrhosis.
› Verified 6 days ago
| Entity Name | Sun Life Family Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891913166 PECOS PAC ID: 9335032275 Enrollment ID: O20040205000085 |
News Archive
Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify which patients are more likely to survive by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation, according to researchers at NYU Langone Medical Center.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
ChemGenex Pharmaceuticals Limited and Hospira, Inc. announced today that they have entered into an exclusive agreement to license, develop and commercialize ChemGenex's product candidate omacetaxine mepesuccinate, a novel targeted cytotoxic pharmaceutical product, in Europe, the Middle East and parts of Africa (the Territory).
AG Mednet, the world's largest medical image collection and delivery service announced today that the steady state volume of images transferred by its managed service has surpassed the 2 million/month mark. The company achieved impressive growth in utilization in 2010.
An international research group led by the Centenary Institute has developed a world first genetic risk score (GRS) test able to identify patients at high-risk of developing alcohol-related cirrhosis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel Chung, MD Po Box 10097, Casa Grande, AZ 85130-0020 Ph: (520) 836-3446 | Daniel Chung, MD 865 N Arizola Rd, Casa Grande, AZ 85122-6011 Ph: (520) 836-3446 |
News Archive
Although the chances of surviving advanced melanoma aren't very good with current therapies, some patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify which patients are more likely to survive by analyzing the activity of hundreds of genes involved in the immune response and gene proliferation, according to researchers at NYU Langone Medical Center.
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrinology, today announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data demonstrating the single agent activity of perifosine (KRX-0401) for the treatment of advanced Waldenstrom's Macroglobulinemia ("Waldenstrom's"), will appear in the February 1, 2010 issue of the Journal of Clinical Cancer Research.
ChemGenex Pharmaceuticals Limited and Hospira, Inc. announced today that they have entered into an exclusive agreement to license, develop and commercialize ChemGenex's product candidate omacetaxine mepesuccinate, a novel targeted cytotoxic pharmaceutical product, in Europe, the Middle East and parts of Africa (the Territory).
AG Mednet, the world's largest medical image collection and delivery service announced today that the steady state volume of images transferred by its managed service has surpassed the 2 million/month mark. The company achieved impressive growth in utilization in 2010.
An international research group led by the Centenary Institute has developed a world first genetic risk score (GRS) test able to identify patients at high-risk of developing alcohol-related cirrhosis.
› Verified 6 days ago
Richard T Fleming, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1683 E Florence Blvd, Suite #7 Nextcare Urgent Care, Casa Grande, AZ 85122 Phone: 520-876-0164 Fax: 520-876-0801 | |
Mrs. Leann Vanduyn, NP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 865 N Arizola Rd, Casa Grande, AZ 85122 Phone: 520-836-3446 Fax: 520-836-8807 | |
William E Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 7555 N Overfield Rd, Casa Grande, AZ 85194 Phone: 520-723-9030 Fax: 520-723-9181 | |
Brian L Seyler, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1856 E Florence Blvd, Casa Grande, AZ 85222 Phone: 520-836-2514 Fax: 520-836-9326 | |
Ann Marie Gaston, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1676 E Mcmurray Blvd Ste 1, Casa Grande, AZ 85122 Phone: 520-316-0688 | |
Aniceto C Gonda X, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1760 E Florence Blvd, Ste 260, Casa Grande, AZ 85222 Phone: 520-836-3600 Fax: 520-836-6757 | |
Analiah Mahinalani Patrice, ND Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1860 E Salk Dr Ste B1, Casa Grande, AZ 85122 Phone: 602-845-0396 Fax: 888-862-2418 |